A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
Asperger's Disorder, Pervasive Developmental Disorder
About this trial
This is an interventional treatment trial for Asperger's Disorder focused on measuring Aggression, Behavioral symptoms
Eligibility Criteria
Inclusion Criteria: Mental age of 18 months Diagnosis of Asperger's Disorder or Pervasive Developmental Disorder Good health overall Free of all psychotropic medication for 2 weeks Exclusion Criteria: Weight less than 15kg Subjects who have received an adequate trial of aripiprazole An active seizure disorder A significant medical condition History of neuroleptic malignant syndrome Females with positive Beta human chorionic gonadotropin(HCG) pregnancy test
Sites / Locations
- Riley Hospital, Riley Child and Adolescent Psychiatry Clinic
Arms of the Study
Arm 1
Experimental
Aripiprazole
Aripiprazole 5 mg per day for 2 weeks, then can be increased to 10mg per day if tolerated for 2 weeks, then can be increased to 15 mg per day for 4 weeks.